GNS Healthcare Presents Results of Metastatic Colorectal Cancer Collaboration with the Alliance for Clinical Trials in Oncology at ESMO 2018

Study identifies clinical and molecular drivers of survival at baseline to allow better risk stratification at initiation of treatment CAMBRIDGE, Mass.– [October 22, 2018] – GNS Healthcare (GNS), a leading precision medicine company, presented results in metastatic colorectal cancer this week from their most recent collaboration with the Alliance for Clinical Trials in Oncology (Alliance) […]

GNS Healthcare and Alliance for Clinical Trials in Oncology Present Results of Causal Modeling that Identifies Clinical and Molecular Drivers of Survival in Colorectal Cancer Patients

Results presented at ASCO 2018 Annual Meeting in Chicago show drivers at baseline allow better risk stratification at initiation of treatment CAMBRIDGE, Mass- June 4, 2018 – GNS Healthcare (GNS), a leading precision medicine company, together with the Alliance for Clinical Trials in Oncology (Alliance), announced today the presentation of a poster supporting results that the […]